Watch Ticker

Clearmind Medicine Inc. Common Shares

Go to Clearmind Medicine Inc. Common Shares Website

$0.98

0.00 (0.00%)

Live

Previous Close

$0.98

Day Range

$0 - $0

Previous Day Range

$0.9602 - $1

Market Cap

$5.2 million USD

Day Vol.

Previous Day Vol.

34558

Currency

USD

Primary Exchange

Nasdaq

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight

The substance use disorder market is expected to grow between 2025 and 2034, driven by greater awareness, the introduction of new therapies, and ongoing research and development efforts. The report covers the market assessment of Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder.

Related tickers: ADIL, CMND, BTAI, INDV.

Read Full Article

N/A - SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

SciSparc and Clearmind Medicine have filed an international patent application for a novel treatment targeting anorexia, bulimia, and other eating disorders. The treatment combines 3-Methylmethcathinone (3-MMC) with SciSparc's Palmitoylethanolamide (PEA) to address the complex neurobiological and psychological factors associated with eating disorders.

Related tickers: CMND.

Read Full Article

Trending Tickers

Please sign in to view